Breaking

Congress races against 3-week deadline to tackle massive year-end legislative agenda
Ukraine peace talks productive as ex-government official says country rethinking ‘uncompromising’ stance
Trump gave Maduro ultimatum to flee Venezuela as land operations loom: report
Trump says ‘don’t read anything into it’ when asked about declaring Venezuela’s airspace closed
Trump envoy Steve Witkoff heads to Moscow as Ukraine peace talks gain momentum
Trump says he believes Hegseth ‘100%’ on Venezuelan drug boat strike denial amid allegations
Trump offers to release his October MRI results, insists scan wasn’t of his brain
Altech Batteries LtdBoard Renewal and Strategic Focus

Business
Politics
Investing
Stocks
Search for:

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Expands REE and Uranium Footprint at Sybella-Barkly

December 1, 2025

Altech Batteries LtdBoard Renewal and Strategic Focus

December 1, 2025

Locksley Resources Limitedto Establish ADR Program with BNY Mellon

December 1, 2025

Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (350)
- Investing (2,024)
- Politics (2,358)
- Stocks (321)

Disclaimer: globalinvestingtrends.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 globalinvestingtrends.com | All Rights Reserved

Top

Business
Politics
Investing
Stocks

Type above and press Enter to search. Press Esc to cancel.